Atos issued a business plan in early September, so the Q3 numbers to the end of September were previously guided.  The actual numbers confirm

Results this morning are a continuation of the membership tailspin the company has been in for years now, even as it seems to be slowing to inside -

Please find our updated analysis of Oriflame here. 

It’s finally happening. Membership is beginning to turn around and even a little faster than we imagined. But that’s the good news - all of it. The turnaround is effectively too

Oriflame results today were miserable as usual but better than forecast - for the first time... Specifically, the company improved its GM vs. last quarter by more than expected and almost to last year's level (which was

Please find our updated analysis of Oriflame here.

So the Felix household bought a blender the other day. It’s a great way to fix up smoothies in no time and it’s striking to see the ingredients blend to the point where they are no longer recognisable. In a way, Oriflame results in the last six months have been strikingly

The company delivered results close to advertised - in particular regarding its turnaround program, which is encouraging of course. Members and sales however

Please find our updated and improved model of Oriflame here.

Even Sweden has Fata Morganas. Or so it appeared to us when we saw progress evaporate in Q3, pushing out any stabilisation by another few quarters. The new cost savings program appears

Results this quarter were again behind our expectations. Management, sounding much improved this time, outlined its cost restructuring plan, which

Please find our updated analysis of Oriflame here.

On the surface, little has changed since we last looked at the name ahead of its Q2 results. It remains as uninvestible as it was then. But aside from bonds trading down and then seemingly catching a bid in the 30s, at least one metric has continued to improve, such that for a

Members fell even faster than we had projected and so did revenue. As most dissenting members are the novices (think churn is 80%), we now see revenue/member almost

Please find our updated analysis here.

It’s less a question of price than it is of time. The bonds have dropped just above 50c/€ as not even the much anticipated China reopening could arrest the ongoing slide of member numbers and consequently of revenue. Not a single region is visibly

Please find our updated analysis of Oriflame here.

We had been more negative than many with whom we discussed the name earlier this year, but the results in fact undercut even our expectations. By comparison the bonds are however